Evaluation of Anticancer Activity of Nucleoside–Nitric Oxide Photo-Donor Hybrids
Open Access
Abstract
Herein, we report the synthesis of a new hybrid compound based on a 2′-deoxyuridine nucleoside conjugated with a NO photo-donor moiety (dU-t-NO) via CuAAC click chemistry. Hybrid dU-t-NO, as well as two previously reported 2′-deoxyadenosine based hybrids (dAdo-S-NO and dAdo-t-NO), were evaluated for their cytotoxic and cytostatic activities in selected cancer cell lines. dAdo-S-NO and dAdo-t-NO hybrids displayed higher activity with respect to dU-t-NO. All hybrids showed effective release of NO in the micromolar range. The photochemical behavior of the newly reported hybrid, dU-t-NO, was studied in the RKO colon carcinoma cell line, whereas the dAdo-t-NO hybrid was tested in both colon carcinoma RKO and hepatocarcinoma Hep 3B2.1-7 cell lines to evaluate the potential effect of NO released upon irradiation on cell viability. A customized irradiation apparatus for in vitro experiments was also designed.Keywords
This publication has 47 references indexed in Scilit:
- Click Chemistry and Targeted Degradation: A Winning Combination for Medicinal Chemists?ChemMedChem, 2023
- Global burden of primary liver cancer in 2020 and predictions to 2040Journal of Hepatology, 2022
- Global colorectal cancer burden in 2020 and projections to 2040Translational Oncology, 2021
- Small molecules for great solutions: Can nitric oxide-releasing nanomaterials overcome drug resistance in chemotherapy?Biochemical Pharmacology, 2020
- 1,2,3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationshipsEuropean Journal of Medicinal Chemistry, 2019
- The effect of nitric oxide on mitochondrial respirationNitric Oxide, 2019
- Preface to this special journal issue on nitric oxide chemistry and biologyArchives of Pharmacal Research, 2009
- Inhaled NO as a therapeutic agentCardiovascular Research, 2007
- Multi-target therapeutics: when the whole is greater than the sum of the partsDrug Discovery Today, 2007
- Molecular mechanisms of drug resistanceThe Journal of Pathology, 2005